Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul McCullagh

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Cancer Medicine|May 19, 2025
FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation InhibitorsKayla Bastian, Margarita Orozco-Moreno, Huw Thomas, et al.
The Journal of Pathology|August 7, 2023
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progressionEmma Scott, Emily Archer Goode, Rebecca Garnham, et al.
Oncogene|February 1, 2023
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growthEmma Scott, Kirsty Hodgson, Beatriz Calle, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Cancer Medicine|May 19, 2025
FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation InhibitorsKayla Bastian, Margarita Orozco-Moreno, Huw Thomas, et al.
The Journal of Pathology|August 7, 2023
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progressionEmma Scott, Emily Archer Goode, Rebecca Garnham, et al.
Oncogene|February 1, 2023
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growthEmma Scott, Kirsty Hodgson, Beatriz Calle, et al.
Pageof 4